首页 › 基金 › MITCHELL CAPITAL MANAGEMENT CO › GRDN

MITCHELL CAPITAL MANAGEMENT CO 对 GRDN 的持仓历史

GUARDIAN PHARMACY SVCS INC · 日常消费

MITCHELL CAPITAL MANAGEMENT CO 在 Q2 2026 的 13F 申报中披露持有 GRDN(GUARDIAN PHARMACY SVCS INC)143,873 股,市值约 US$6.0M,约占其申报组合的 0.95%,在其申报持仓中市值排名第 30 位。 MITCHELL CAPITAL MANAGEMENT CO 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)143.87K 股
申报持仓市值$6.02M
组合权重0.95%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

MITCHELL CAPITAL MANAGEMENT CO 对 GRDN 的持仓演变

MITCHELL CAPITAL MANAGEMENT CO 于 Q2 2026 首次披露 GRDN 持仓:143,873 股(约 US$6.0M)。

逐季持仓明细

季度股数金额变化
Q2 2026 143.87K $6.02M 新进

关于 GRDN 与 13F 数据

GRDN(GUARDIAN PHARMACY SVCS INC)属于日常消费行业。我们追踪的基金中还有 71 只申报持有 GRDN,申报仓位最大的包括:Valiant Capital Management, L.P. (US$49.7M), BOONE CAPITAL MANAGEMENT LLC (US$29.8M), Aristotle Capital Boston, LLC (US$17.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 GRDN 的基金

查看 GRDN 的全部基金持有人 →

常见问题

How long has MITCHELL CAPITAL MANAGEMENT CO held GRDN?

MITCHELL CAPITAL MANAGEMENT CO has disclosed GRDN holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is MITCHELL CAPITAL MANAGEMENT CO's current position in GRDN?

As of Q2 2026, MITCHELL CAPITAL MANAGEMENT CO holds 143.87K shares of GRDN (GUARDIAN PHARMACY SVCS INC), valued at $6.02M, representing 0.95% of its reported portfolio and ranking #30.

Has MITCHELL CAPITAL MANAGEMENT CO been buying or selling GRDN?

In the latest 13F filing (Q2 2026), MITCHELL CAPITAL MANAGEMENT CO newly opened its position in GRDN.

Which other funds hold GRDN?

Other major institutional holders of GRDN include Valiant Capital Management, L.P., BOONE CAPITAL MANAGEMENT LLC, Aristotle Capital Boston, LLC, among 71 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.